BRAF mutation assessment in papillary thyroid cancer: are we ready to use it in clinical practice?
- 24 December 2013
- journal article
- Published by Springer Nature in Endocrine
- Vol. 45 (3) , 341-343
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Immunohistochemical Detection of Mutated BRAF V600E Supports the Clonal Origin of BRAF-Induced Thyroid Cancers Along the Spectrum of Disease ProgressionThe Journal of Clinical Endocrinology & Metabolism, 2013
- Ultrasound Sensitivity for Thyroid Malignancy Is Increased by Real-Time Elastography: A Prospective Multicenter StudyThe Journal of Clinical Endocrinology & Metabolism, 2012
- Thin core biopsy should help to discriminate thyroid nodules cytologically classified as indeterminate. A new sampling techniqueEndocrine, 2012
- The Primary Occurrence ofBRAFV600EIs a Rare Clonal Event in Papillary Thyroid CarcinomaThe Journal of Clinical Endocrinology & Metabolism, 2012
- BRAFMutations in Hairy-Cell LeukemiaNew England Journal of Medicine, 2011
- Mutational Profile of Advanced Primary and Metastatic Radioactive Iodine-Refractory Thyroid Cancers Reveals Distinct Pathogenetic Roles forBRAF, PIK3CA, andAKT1Cancer Research, 2009
- Clinical implications of BRAF mutation in thyroid carcinomaTrends in Endocrinology & Metabolism, 2008
- BRAF mutation in thyroid cancerEndocrine-Related Cancer, 2005
- BRAF Mutations in Thyroid Tumors Are Restricted to Papillary Carcinomas and Anaplastic or Poorly Differentiated Carcinomas Arising from Papillary CarcinomasThe Journal of Clinical Endocrinology & Metabolism, 2003
- Mutations of the BRAF gene in human cancerNature, 2002